EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Proton Radiotherapy Significantly Reduces Pneumonia in Patients With Esophageal Cancer

Mark L Frederiks, Boudewijn van Etten, Wendy Kelder, Margriet Dieters, Jannet C Beukema, Charlotte IJsbrandy, Jacco J de Haan, Erik W Korevaar, Jan Willem Haveman, Ewoud Schuit, Peter van Luijk, Johannes A Langendijk und 1 weitere

International Journal of Radiation Oncology*Biology*Physics · 2025

DOI: 10.1016/j.ijrobp.2024.12.036 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2025. Verfasst von Mark L Frederiks und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Electronic address: m.l.f…. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Proton Therapy, Pneumonia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: KWF Kankerbestrijding, European Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Neoadjuvant chemoradiation therapy (RT) (nCRT) followed by surgical resection is the current standard of care for patients with esophageal cancer (EC). This treatment is associated with a variety of complications, with pneumonia being the most common. We hypothesized that proton RT (PRT) can significantly reduce the incidence of pneumonia compared with photon RT (PhRT). METHODS AND MATERIALS: We performed an analysis on a prospective cohort of patients with EC who completed nCRT with PRT or PhRT and underwent esophagectomy between October 2014 and June 2022. Multivariable logistic regression was used to analyze the effect of the RT technique on pneumonia while correcting for confounders. To access the dose-effect relationships, dose-volume histogram parameters of the lungs and the heart were analyzed using a principal component (PC) analysis. RESULTS: We included 313 patients, of whom 28% developed pneumonia. The incidence was lower after PRT compared with PhRT (12% vs 32%, P < .01). PRT was associated with a significant reduction of the incidence of pneumonia (odds ratio [OR], 0.33; 95% CI, 0.14-0.72; P = .01), even when correcting for surgical approach and planning target volume size. Three PCs were identified: PC1: associated with the mean dose in the heart and lungs, PC2: associated with the distribution of dose between the lungs and the heart, and PC3: associated with the volume receiving a low dose (≤20 Gy). If the dose-related variables were replaced by the PCs, PC1 (OR, 1.1; 95% CI, 1.02-1.22) and PC3 (OR, 1.27; 95% CI, 1.06-1.53) were significantly associated with pneumonia. PRT had significantly lower values for both PC1 and PC3, compared with PhRT. CONCLUSIONS: PRT significantly reduces the incidence of pneumonia compared with PhRT in patients with EC treated with nCRT followed by surgical resection. The reduction of pneumonia was associated with the lower mean dose and a reduction of the volume irradiated to low doses in the lungs and/or heart.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal NeoplasmsProton TherapyPneumoniaHumansMaleFemaleMiddle AgedAgedProspective StudiesEsophagectomyLungNeoadjuvant TherapyPhotonsIncidenceHeartRadiotherapy DosageOrgans at Risk

Autor:innen und Institutionen

  • Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Electronic address: m.l.frederiks@umcg.nl.
  • Department of Surgery, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Department of Surgery, Martini Hospital Groningen, Groningen, The Netherlands.
  • Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Department of Epidemiology & Health Economics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Förderung

  • KWF Kankerbestrijding
  • European Commission

Zitieren

APA

Frederiks, M. L., van Etten, B., Kelder, W., Dieters, M., Beukema, J. C., IJsbrandy, C., de Haan, J. J., Korevaar, E. W., Haveman, J. W., Schuit, E., van Luijk, P., Langendijk, J. A., & Muijs, C. T. (2025). Proton Radiotherapy Significantly Reduces Pneumonia in Patients With Esophageal Cancer. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2024.12.036

Vancouver

Frederiks ML, van Etten B, Kelder W, Dieters M, Beukema JC, IJsbrandy C, et al. Proton Radiotherapy Significantly Reduces Pneumonia in Patients With Esophageal Cancer. International Journal of Radiation Oncology*Biology*Physics. 2025. doi:10.1016/j.ijrobp.2024.12.036

BibTeX
@article{Frederiks2025,
  author = {Frederiks, Mark L and van Etten, Boudewijn and Kelder, Wendy and Dieters, Margriet and Beukema, Jannet C and IJsbrandy, Charlotte and de Haan, Jacco J and Korevaar, Erik W and Haveman, Jan Willem and Schuit, Ewoud and van Luijk, Peter and Langendijk, Johannes A and Muijs, Christina T},
  title = {Proton Radiotherapy Significantly Reduces Pneumonia in Patients With Esophageal Cancer},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2025},
  doi = {10.1016/j.ijrobp.2024.12.036}
}
Kostenlos starten →